Citations (82)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ramón Cacabelos. (2020) Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer’s disease. Expert Opinion on Drug Metabolism & Toxicology 16:8, pages 673-701.
Read now
Read now
Byron Creese, Miguel Vasconcelos Da Silva, Iskandar Johar & Clive Ballard. (2018) The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer’s disease. Expert Review of Neurotherapeutics 18:6, pages 461-467.
Read now
Read now
Danielle S Cha & Roger S McIntyre. (2012) Treatment-emergent adverse events associated with atypical antipsychotics. Expert Opinion on Pharmacotherapy 13:11, pages 1587-1598.
Read now
Read now
Articles from other publishers (79)
Kirstine Skov Benthien, Laura Victoria Jedig Lech, Hanne Birke, Sidsel Maria Jørgensen, Tina Andersen, Stine Vest Hansen, Jon Trærup Andersen, Kristian Karstoft, Michaela Schiøtz & Charlotte Vermehren. (2023) Protocol for DEprescribing and Care to reduce Antipsychotics in Dementia (DECADE)–A hybrid effectiveness-implementation pilot study. PLOS ONE 18:11, pages e0294024.
Crossref
Crossref
Anders M. Jensen, Rhonda L. Wilson, Birthe D. Pedersen, Lise Hounsgaard & Ellen B. Tingleff. (2022) Nursing care of people with dementia in an orthopaedic acute care setting: An integrative literature review. Journal of Clinical Nursing 32:9-10, pages 2298-2318.
Crossref
Crossref
Mei-Feng Huang, Wei-Ju Lee, Yi-Chun Yeh, Yung-Shuan Lin, Hsiu-Fen Lin, Shuu-Jiun Wang, Yi-Hsin Yang, Cheng-Sheng Chen & Jong-Ling Fuh. (2022) Neuropsychiatric symptoms and mortality among patients with mild cognitive impairment and dementia due to Alzheimer's disease. Journal of the Formosan Medical Association 121:9, pages 1705-1713.
Crossref
Crossref
Zahinoor Ismail, Byron Creese, Dag Aarsland, Helen C. Kales, Constantine G. Lyketsos, Robert A. Sweet & Clive Ballard. (2022) Psychosis in Alzheimer disease — mechanisms, genetics and therapeutic opportunities. Nature Reviews Neurology 18:3, pages 131-144.
Crossref
Crossref
Sina Nawzad, Wiepke Cahn & Heshu Abdullah-Koolmees. (2022) The efficacy of antipsychotics in the treatment of physical aggressive behavior in patients with dementia in nursing homes. Therapeutic Advances in Psychopharmacology 12, pages 204512532210974.
Crossref
Crossref
S.W. Johnny Lau, Danijela Gnjidic & Darrell R. Abernethy. 2022. Atkinson's Principles of Clinical Pharmacology. Atkinson's Principles of Clinical Pharmacology
479
498
.
Stephanie Hsieh, Jing Yuan, Z. Kevin Lu & Minghui Li. (2021) Deprescribing Antipsychotics Based on Real-World Evidence to Inform Clinical Practice: Safety Considerations in Managing Older Adults with Dementia. Frontiers in Pharmacology 12.
Crossref
Crossref
Adam H. Dyer, Claire Murphy, Brian Lawlor, Sean P. Kennelly & for the NILVAD Study Group. (2021) Long‐term antipsychotic use and cognitive decline in community‐dwelling older adults with mild–moderate Alzheimer disease: Data from NILVAD. International Journal of Geriatric Psychiatry 36:11, pages 1708-1721.
Crossref
Crossref
Juanita Breen, Barbara C. Wimmer, Chloé C.H. Smit, Helen Courtney-Pratt, Katherine Lawler, Katharine Salmon, Andrea Price & Lynette R. Goldberg. (2021) Interdisciplinary Perspectives on Restraint Use in Aged Care. International Journal of Environmental Research and Public Health 18:21, pages 11022.
Crossref
Crossref
Asif Raza Khowaja, Christina Krause, Colleen Kennedy, Ben Ridout, Sarah Carriere & Craig Mitton. (2021) Cost-effectiveness of a Province-wide Quality Improvement Initiative for Reducing Potentially Inappropriate Use of Antipsychotics in Long-Term Care in British Columbia, Canada. PharmacoEconomics - Open 5:3, pages 491-504.
Crossref
Crossref
Brent P. Forester, Feyza Marouf, Ben Legesse, Olivia I. Okereke & Deborah Blacker. 2021. Introduction to Psychiatry. Introduction to Psychiatry
263
288
.
. 2021. Introduction to Psychiatry. Introduction to Psychiatry.
Amalie Elisabeth Moth, Pernille Hølmkjær, Anne Holm, Maarten Pieter Rozing & Gritt Overbeck. (2021) What Makes Deprescription of Psychotropic Drugs in Nursing Home Residents with Dementia so Challenging? A Qualitative Systematic Review of Barriers and Facilitators. Drugs & Aging 38:8, pages 671-685.
Crossref
Crossref
Thorbjorg Jonsdottir & Esther Christina Gunnarsson. (2021) Understanding Nurses’ Knowledge and Attitudes Toward Pain Assessment in Dementia: A Literature Review. Pain Management Nursing 22:3, pages 281-292.
Crossref
Crossref
Vijayendra Waykar, Katherine Wourms, Ganapathy Bhat & Alison Farrow. (2021) Antipsychotic use in dementia – local quality improvement initiative. Progress in Neurology and Psychiatry 25:1, pages 26-30.
Crossref
Crossref
Liza Jm van de Rijt, Alexandra R Feast, Victoria Vickerstaff, Frank Lobbezoo & Elizabeth L Sampson. (2020) Prevalence and associations of orofacial pain and oral health factors in nursing home residents with and without dementia. Age and Ageing 49:3, pages 418-424.
Crossref
Crossref
Minah Amor Gaviola, Kerry J. Inder, Sophie Dilworth, Elizabeth G. Holliday & Isabel Higgins. (2019) Impact of individualised music listening intervention on persons with dementia: A systematic review of randomised controlled trials. Australasian Journal on Ageing 39:1, pages 10-20.
Crossref
Crossref
Daniel R. Bateman, Sascha Gill, Sophie Hu, Erin D. Foster, Myuri T. Ruthirakuhan, Allis F. Sellek, Moyra E. Mortby, Veronika Matušková, Kok Pin Ng, Rawan M. Tarawneh, Yvonne Freund‐Levi, Sanjeev Kumar, Serge Gauthier, Paul B. Rosenberg, Fabricio Ferreira de Oliveira, D. P. Devanand, Clive Ballard & Zahinoor Ismail. (2020) Agitation and impulsivity in mid and late life as possible risk markers for incident dementia. Alzheimer's & Dementia: Translational Research & Clinical Interventions 6:1.
Crossref
Crossref
Valeria Calsolaro, Rachele Antognoli, Chukwuma Okoye & Fabio Monzani. (2019) The Use of Antipsychotic Drugs for Treating Behavioral Symptoms in Alzheimer’s Disease. Frontiers in Pharmacology 10.
Crossref
Crossref
Marie Turmo Lornstad, Marte Aarøen, Sverre Bergh, Jūratė Šaltytė Benth & Anne-Sofie Helvik. (2019) Prevalence and persistent use of psychotropic drugs in older adults receiving domiciliary care at baseline. BMC Geriatrics 19:1.
Crossref
Crossref
Jason M. Randle, George Heckman, Mark Oremus & Joanne Ho. (2019) Intermittent antipsychotic medication and mortality in institutionalized older adults: A scoping review. International Journal of Geriatric Psychiatry 34:7, pages 906-920.
Crossref
Crossref
Dilbagh Gill, Saleh Almutairi & Parastou Donyai. (2019) “The Lesser of Two Evils” Versus “Medicines not Smarties”: Constructing Antipsychotics in Dementia. The Gerontologist 59:3, pages 570-579.
Crossref
Crossref
. 2019. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen
1
119
.
Tilman Steinert & Sophie Hirsch. 2019. S3-Leitlinie Verhinderung von Zwang: Prävention und Therapie aggressiven Verhaltens bei Erwachsenen. S3-Leitlinie Verhinderung von Zwang: Prävention und Therapie aggressiven Verhaltens bei Erwachsenen
95
152
.
Steven Hoover & Mary Sano. 2019. Handbook on the Neuropsychology of Aging and Dementia. Handbook on the Neuropsychology of Aging and Dementia
335
353
.
Aisling A. Jennings, Tony Foley, Kieran A. Walsh, Alice Coffey, John P. Browne & Colin P. Bradley. (2018) General practitioners’ knowledge, attitudes and experiences of managing behavioural and psychological symptoms of dementia: protocol of a mixed methods systematic review and meta-ethnography. Systematic Reviews 7:1.
Crossref
Crossref
Bannin De Witt Jansen, Kevin Brazil, Peter Passmore, Hilary Buchanan, Doreen Maxwell, Sonja McIlfatrick, Sharon M. Morgan, Max Watson & Carole Parsons. (2018) “A tool doesn't add anything”. The importance of added value: Use of observational pain tools with patients with advanced dementia approaching the end of life-a qualitative study of physician and nurse experiences and perspectives. International Journal of Geriatric Psychiatry 33:10, pages 1346-1354.
Crossref
Crossref
Aisling A. Jennings, Tony Foley, Kieran A. Walsh, Alice Coffey, John P. Browne & Colin P. Bradley. (2018) General practitioners' knowledge, attitudes, and experiences of managing behavioural and psychological symptoms of dementia: A mixed-methods systematic review. International Journal of Geriatric Psychiatry 33:9, pages 1163-1176.
Crossref
Crossref
Abdullah Agit, Cafer Balci, Burcu Balam Yavuz, Eylem Cankurtaran, Mehmet Emin Kuyumcu, Meltem Halil, Servet Arıogul & Mustafa Cankurtaran. (2018) An Iceberg Phenomenon in Dementia: Pain. Journal of Geriatric Psychiatry and Neurology 31:4, pages 186-193.
Crossref
Crossref
Saleh Almutairi, Kate Masters & Parastou Donyai. (2018) The health professional experience of using antipsychotic medication for dementia in care homes: A study using grounded theory and focussing on inappropriate prescribing. Journal of Psychiatric and Mental Health Nursing 25:5-6, pages 307-318.
Crossref
Crossref
Ellen Van Leeuwen, Mirko Petrovic, Mieke L van Driel, An IM De Sutter, Robert Vander Stichele, Tom Declercq & Thierry Christiaens. (2018) Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia. Cochrane Database of Systematic Reviews 2022:4.
Crossref
Crossref
Clive Ballard, Anne Corbett, Martin Orrell, Gareth Williams, Esme Moniz-Cook, Renee Romeo, Bob Woods, Lucy Garrod, Ingelin Testad, Barbara Woodward-Carlton, Jennifer Wenborn, Martin Knapp & Jane Fossey. (2018) Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: A cluster-randomised controlled trial. PLOS Medicine 15:2, pages e1002500.
Crossref
Crossref
Stephen J. Ralph & Anthony J. Espinet. (2018) Increased All-Cause Mortality by Antipsychotic Drugs: Updated Review and Meta-Analysis in Dementia and General Mental Health Care. Journal of Alzheimer's Disease Reports 2:1, pages 1-26.
Crossref
Crossref
Laurence J. Kinsella & George T. Grossberg. 2018. Clinical Psychopharmacology for Neurologists. Clinical Psychopharmacology for Neurologists
1
4
.
Irene Røen, Geir Selbæk, Øyvind Kirkevold, Knut Engedal, Ingelin Testad & Sverre Bergh. (2017) Resource Use and Disease Course in dementia - Nursing Home (REDIC-NH), a longitudinal cohort study; design and patient characteristics at admission to Norwegian nursing homes. BMC Health Services Research 17:1.
Crossref
Crossref
Rosemary H Gibson, Philippa H Gander, Anthony C Dowell & Linda M Jones. (2016) Non-pharmacological interventions for managing dementia-related sleep problems within community dwelling pairs: A mixed-method approach. Dementia 16:8, pages 967-984.
Crossref
Crossref
Sienna Caspar, Erin D Davis, Aimee Douziech & David R Scott. (2017) Nonpharmacological Management of Behavioral and Psychological Symptoms of Dementia: What Works, in What Circumstances, and Why?. Innovation in Aging 1:3.
Crossref
Crossref
Clive Ballard, Martin Orrell, Yongzhong Sun, Esme Moniz-Cook, Jane Stafford, Rhiannon Whitaker, Bob Woods, Anne Corbett, Sube Banerjee, Ingelin Testad, Lucy Garrod, Zunera Khan, Barbara Woodward-Carlton, Jennifer Wenborn & Jane Fossey. (2017) Impact of antipsychotic review and non-pharmacological intervention on health-related quality of life in people with dementia living in care homes: WHELD-a factorial cluster randomised controlled trial. International Journal of Geriatric Psychiatry 32:10, pages 1094-1103.
Crossref
Crossref
Bannin De Witt Jansen, Kevin Brazil, Peter Passmore, Hilary Buchanan, Doreen Maxwell, Sonja J McIlfatrick, Sharon M Morgan, Max Watson & Carole Parsons. (2016) ‘There’s a Catch-22’ – The complexities of pain management for people with advanced dementia nearing the end of life: A qualitative exploration of physicians’ perspectives. Palliative Medicine 31:8, pages 734-742.
Crossref
Crossref
Corinne E. Fischer, Winnie Qian, Tom A. Schweizer, Zahinoor Ismail, Eric E. Smith, Colleen P. Millikin & David G. Munoz. (2017) Determining the impact of psychosis on rates of false-positive and false-negative diagnosis in Alzheimer's disease. Alzheimer's & Dementia: Translational Research & Clinical Interventions 3:3, pages 385-392.
Crossref
Crossref
Tristan Ling, Peter Gee, Juanita Westbury, Ivan Bindoff & Gregory Peterson. (2017) An Internet-Based Method for Extracting Nursing Home Resident Sedative Medication Data From Pharmacy Packing Systems: Descriptive Evaluation. Journal of Medical Internet Research 19:8, pages e283.
Crossref
Crossref
Sarah I. Janus, Jeannette G. van Manen, Janine A. van Til, Sytse U. Zuidema & Maarten J. IJzerman. (2017) Pharmacological and non-pharmacological treatment preferences of healthcare professionals and proxies for challenging behaviors in patients with dementia. International Psychogeriatrics 29:8, pages 1377-1389.
Crossref
Crossref
Elizabeta B. Mukaetova-Ladinska. (2017) Silent lives: why do we fail community-dwelling people with dementia?. Age and Ageing 46:3, pages 341-343.
Crossref
Crossref
Martin R. Farlow & Tatyana A. Shamliyan. (2017) Benefits and harms of atypical antipsychotics for agitation in adults with dementia. European Neuropsychopharmacology 27:3, pages 217-231.
Crossref
Crossref
Carole Parsons. (2016) Polypharmacy and inappropriate medication use in patients with dementia: an underresearched problem. Therapeutic Advances in Drug Safety 8:1, pages 31-46.
Crossref
Crossref
. 2017. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen
1
111
.
Corinne E. Fischer & Robert A. Sweet. (2016) Psychosis in Alzheimer’s Disease: a Review of Recent Research Findings. Current Behavioral Neuroscience Reports 3:4, pages 308-317.
Crossref
Crossref
Sarah I. M. Janus, Jeannette G. van Manen, Maarten J. IJzerman & Sytse U. Zuidema. (2016) Psychotropic drug prescriptions in Western European nursing homes. International Psychogeriatrics 28:11, pages 1775-1790.
Crossref
Crossref
Assaf Shelef, Yoram Barak, Uri Berger, Diana Paleacu, Shelly Tadger, Igor Plopsky & Yehuda Baruch. (2016) Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study. Journal of Alzheimer's Disease 51:1, pages 15-19.
Crossref
Crossref
Dawn Dowding, Valentina Lichtner, Nick Allcock, Michelle Briggs, Kirstin James, John Keady, Reena Lasrado, Elizabeth L. Sampson, Caroline Swarbrick & S. José Closs. (2016) Using sense-making theory to aid understanding of the recognition, assessment and management of pain in patients with dementia in acute hospital settings. International Journal of Nursing Studies 53, pages 152-162.
Crossref
Crossref
Kang Soo Lee, Sang-Hwan Kim & Hee-Jin Hwang. (2015) Behavioral and Psychological Symptoms of Dementia and Antipsychotic Drug Use in the Elderly with Dementia in Korean Long-Term Care Facilities. Drugs - Real World Outcomes 2:4, pages 363-368.
Crossref
Crossref
Ane Nørgaard, Christina Jensen-Dahm, Christiane Gasse, Hanne Vibe Hansen & Gunhild Waldemar. (2015) Time Trends in Antipsychotic Drug Use in Patients with Dementia: A Nationwide Study. Journal of Alzheimer's Disease 49:1, pages 211-220.
Crossref
Crossref
Carmelle Peisah, Julie-Anne Strukovski, Chanaka Wijeratne, Rosalind Mulholland, Georgina Luscombe & Henry Brodaty. (2015) The development and testing of the quality use of medications in dementia (QUM-D): a tool for quality prescribing for behavioral and psychological symptoms of dementia (BPSD). International Psychogeriatrics 27:8, pages 1313-1322.
Crossref
Crossref
Francisca Magalhães Scoralick, Einstein Francisco Camargos, Marco Polo Dias Freitas & Otávio Toledo Nóbrega. (2015) Outpatient treatment of sleep disorders in Alzheimer patients. Einstein (São Paulo) 13:3, pages 430-434.
Crossref
Crossref
Francisca Galindo-Garre, Ladislav Volicer & Jenny T. van der Steen. (2015) Factors Related to Rejection of Care and Behaviors Directed towards Others: A Longitudinal Study in Nursing Home Residents with Dementia. Dementia and Geriatric Cognitive Disorders Extra 5:1, pages 123-134.
Crossref
Crossref
Clive Ballard, Alan Thomas, Stephen Gerry, Ly-Mee Yu, Dag Aarsland, Claire Merritt, Anne Corbett, Christopher Davison, Narenda Sharma, Zunera Khan, Byron Creese, Paul Loughlin, Carol Bannister, Alistair Burns, Soe Nyunt Win & Zuzana Walker. (2015) A Double-Blind Randomized Placebo-Controlled Withdrawal Trial Comparing Memantine and Antipsychotics for the Long-Term Treatment of Function and Neuropsychiatric Symptoms in People With Alzheimer's Disease (MAIN-AD). Journal of the American Medical Directors Association 16:4, pages 316-322.
Crossref
Crossref
. 2015. Therapie Psychischer Erkrankungen. Therapie Psychischer Erkrankungen
e1
e96
.
Valentina Lichtner, Dawn Dowding, Philip Esterhuizen, S José Closs, Andrew F Long, Anne Corbett & Michelle Briggs. (2014) Pain assessment for people with dementia: a systematic review of systematic reviews of pain assessment tools. BMC Geriatrics 14:1.
Crossref
Crossref
K. Fassbender & L. Frölich. (2014) Leitlinien zur „Pharmakotherapie neurodegenerativer Demenzen“Guidelines on “pharmacotherapy of neurodegenerative dementia”. Der Nervenarzt 85:12, pages 1589-1602.
Crossref
Crossref
J. Sultana, C. K. Chang, R. D. Hayes, M. Broadbent, R. Stewart, A. Corbett & C. Ballard. (2014) Associations between risk of mortality and atypical antipsychotic use in vascular dementia: a clinical cohort study. International Journal of Geriatric Psychiatry 29:12, pages 1249-1254.
Crossref
Crossref
Jo Thompson Coon, Rebecca Abbott, Morwenna Rogers, Rebecca Whear, Stephen Pearson, Iain Lang, Nick Cartmell & Ken Stein. (2014) Interventions to Reduce Inappropriate Prescribing of Antipsychotic Medications in People With Dementia Resident in Care Homes: A Systematic Review. Journal of the American Medical Directors Association 15:10, pages 706-718.
Crossref
Crossref
T. Gerhard, K. Huybrechts, M. Olfson, S. Schneeweiss, W. V. Bobo, P. M. Doraiswamy, D. P. Devanand, J. A. Lucas, C. Huang, E. S. Malka, R. Levin & S. Crystal. (2018) Comparative mortality risks of antipsychotic medications in community-dwelling older adults. British Journal of Psychiatry 205:1, pages 44-51.
Crossref
Crossref
Gianluca Trifiró, Janet Sultana & Edoardo Spina. (2014) Are the Safety Profiles of Antipsychotic Drugs Used in Dementia the Same? An Updated Review of Observational Studies. Drug Safety 37:7, pages 501-520.
Crossref
Crossref
Ellen Melbye Langballe, Bo Engdahl, Hedvig Nordeng, Clive Ballard, Dag Aarsland & Geir Selbæk. (2014) Short- and Long-term Mortality Risk Associated with the Use of Antipsychotics Among 26,940 Dementia Outpatients: A Population-Based Study. The American Journal of Geriatric Psychiatry 22:4, pages 321-331.
Crossref
Crossref
. 2014. Therapie Psychischer Erkrankungen. Therapie Psychischer Erkrankungen
1
91
.
Clive Ballard & Anne Corbett. (2013) Agitation and aggression in people with Alzheimer's disease. Current Opinion in Psychiatry 26:3, pages 252-259.
Crossref
Crossref
Anne CorbettPaul FrancisClive Ballard. (2013) Safety and Efficacy of Memantine Extended-Release in the Management of Alzheimer's Disease. Clinical Medicine Insights: Therapeutics 5, pages CMT.S7794.
Crossref
Crossref
Trevor Archer & Boo Johansson. 2013. Omics for Personalized Medicine. Omics for Personalized Medicine
289
308
.
Steven Hoover & Mary Sano. 2013. Handbook on the Neuropsychology of Aging and Dementia. Handbook on the Neuropsychology of Aging and Dementia
59
77
.
Stefan Schwarz, Lutz Froelich & Alistair Burns. (2012) Pharmacological treatment of dementia. Current Opinion in Psychiatry 25:6, pages 542-550.
Crossref
Crossref
Ladislav Volicer. (2012) Antipsychotics Do Not Have To Be Used “Off Label” in Dementia. Journal of the American Medical Directors Association 13:6, pages 495-496.
Crossref
Crossref
Serge Gauthier & Pedro Rosa-NetoClive BallardAnne Corbett. 2012. Advances in Alzheimer’s Disease Management. Advances in Alzheimer’s Disease Management
68
79
.
A. Gurevich, V. Guller, Y. N. Berner & S. Tal. (2012) Are atypical antipsychotics safer than typical antipsychotics for treating behavioral and psychological symptoms of dementia?. The journal of nutrition, health & aging 16:6, pages 557-561.
Crossref
Crossref
Susan A. Hall, Nancy N. Maserejian, Carol L. Link, William D. Steers & John B. McKinlay. (2011) Are commonly used psychoactive medications associated with lower urinary tract symptoms?. European Journal of Clinical Pharmacology 68:5, pages 783-791.
Crossref
Crossref
Ian D. Maidment, Chris Fox, Malaz Boustani & Cornelius Katona. (2011) Medication management—the missing link in dementia interventions. International Journal of Geriatric Psychiatry 27:5, pages 439-442.
Crossref
Crossref
Lilian Thorpe, Punam Pahwa, Vernon Bennett, Andrew Kirk & Josephine Nanson. (2012) Clinical Predictors of Mortality in Adults with Intellectual Disabilities with and without Down Syndrome. Current Gerontology and Geriatrics Research 2012, pages 1-11.
Crossref
Crossref
S.W. Johnny Lau & Darrell R. Abernethy. 2012. Principles of Clinical Pharmacology. Principles of Clinical Pharmacology
437
453
.
Linda Nazarko. (2011) Dementia: neuroleptic drugs and alternative treatments. British Journal of Healthcare Assistants 5:7, pages 331-334.
Crossref
Crossref
Debbie Tolson & John E. Morley. (2011) Medical Care in the Nursing Home. Medical Clinics of North America 95:3, pages 595-614.
Crossref
Crossref